Cytodyn Inc (CYDY)

[gfp927z]

Ombow, >> placebo arm be given leronlimab <<


I've seen that happen before but not often, where a drug's efficacy is so compelling that they stop the trial and give the drug to all the patients. That would be great, but more likely the DSMB will merely allow the trial to continue to completion, which is what normally happens.

If CYDY needs 195 patients before doing an interim analysis, that will probably take a while. Have they said how many have been enrolled so far? Thanks.

Of course this will all be moot if the mild/mod trial shows good efficacy next week. But if not, an ultra low entry point (sub dollar) will be created for betting on the severe trial. The bio casino never sleeps, just keep on betting until that pile is gone lol..

GL to everyone